Nexilico Selected as one of the 30 NIH SBIR/STTR awardees to attend the BIO International Convention

Berkeley, CA, March 17, 2020 – Nexilico, Inc. is selected by the National Institutes of Health, as one of the NIH SBIR/STTR awardees to exhibit and showcase their technology at the upcoming Biotechnology Innovation Organization (BIO) International Convention, to be held June 8-11, 2020 in San Diego, CA.

BIO is the world’s largest biotechnology conference and exhibition. Hosted by BIO, the annual event attracts over 17,000 biotech leaders from 65 countries and covers the wide spectrum of life science innovations and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, cell therapy, and more. The key elements of the conference are education, networking, the BIO Exhibition featuring over 1,800 companies, and BIO One-on-One Partnering™, which facilitates more than 45,000 strategic partnering meetings during the three-day event.

This year, there will be a high profile, expansive area of the Exhibition floor branded as the Innovation Zone, a turnkey exhibit space dedicated to showcasing up to 50 NIH SBIR/STTR awardees. In addition, Nexilico will have access to additional opportunitites such as BIO One-on-One Partnering and expert-level education sessions focused on urgent industry topics.